Covid-19. Covid-19
Conditions
Interventions
Intervention 1: Intervention group: In this group, participants will be in the prone position for 90 minutes for the first time. After evaluating the initial outcomes, the participant will be asked to
Sponsors
Khoram-Abad University of Medical Sciences
Eligibility
Sex/Gender
All
Age
18 Years to 65 Years
Inclusion criteria
Inclusion criteria: All patients with COVID-19 based on standard diagnosed test and had at least one respiratory symptom Age between 18 and 65 years Willing to participate in the study
Exclusion criteria
Exclusion criteria: Do not use mechanical ventilation devices Absence of respiratory diseases such as asthma and COPD Not suffering from hypertension No history of heart failure No history of orthopedic and spinal problems No history of neurological diseases Lack of anemia Lack of treatment-induced pulmonary complications such as barometer and chest tube installation No history of thoracic surgery in the last 6 months
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Mean blood pressure. Timepoint: At 0, 30, 60, 90 and 120 minutes after the first intervention. Method of measurement: Digital sphygmomanometer.;Heart rate. Timepoint: At 0, 30, 60, 90 and 120 minutes after the first intervention. Method of measurement: Pulse oximeter device.;Oxygen saturation. Timepoint: At 0, 30, 60, 90 and 120 minutes after the first intervention. Method of measurement: Pulse oximeter device.;Respiratory rate. Timepoint: At 0, 30, 60, 90 and 120 minutes after the first intervention. Method of measurement: Count the number of breaths per minute.;Breath shortness. Timepoint: At 0, 30, 60, 90 and 120 minutes after the first intervention. Method of measurement: Visual analog scale for breath shortness. | — |
Secondary
| Measure | Time frame |
|---|---|
| Hospital stay. Timepoint: Patient discharge time. Method of measurement: Count the number of days a patient is hospitalized.;Percentage of patients transferred to the intensive care unit. Timepoint: At the end of the study. Method of measurement: Percentage of the number of patients who will be transferred to the intensive care unit.;Mortality rate of patients. Timepoint: At the end of the study. Method of measurement: The number of patients who die by the end of the study. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactSajad Yarahmadi
Khoram-Abad University of Medical Sciences
Outcome results
None listed